The U.S. Food and Drug Administration (FDA) has approved Vanda Pharmaceuticals Inc.’s Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Fanapt is an atypical antipsychotic agent that has been used for the acute treatment of patients with schizophrenia since its FDA approval in 2009.   “Manic or mixed episodes associated with bipolar I disorder are highly complex conditions, which require a host of trusted options...